Nubiotic Business offer
Investing in our company will bring every investor stability and financial independence for years to comeShow tariffs
Get more profit
The investment management system forms a package of investment proposals of our company, which includes 8 investment plans. Each investment tariff is supports by the company’s respective business direction and provides profit directly from Nubiotic’s technology sales and independent functional developments to global biotechnology companies.
Take the advantage of your company’s investment opportunities to the fullest and make more profits.
Use your personal account to maintain an own investment statistics.
Progress and develop with our company, climbing the career ladder.
Keep pushing investment and career ideas with advertising and legitimate promotion.
Profit is accrued from Sunday to Monday for AL, GD and IR offers and from Monday to Friday for any other investment offers.
In case the investor uses Gerontology development or Immune research investment plans in the investment process, we draw attention to the fact that the invested amount will not be returned additionally, as it is integrated in equal parts into daily profit accruals. The term of operation of any investment offer is specified in working days, excluding days off.
- [[ ::plan.name ]] ([[ ::plan.name_short ]])
Creation of interactive prosthetics technologies is one of the directions of active development of our company. Using innovative system-on-chip ideas, we create not just chips that can operate under the control of electromagnetic waves emitted by the human brain, but also provide technologies that can bring together prosthetic users by collecting extensive information and constantly providing data to improve the consumer properties of the product and its usability.
Our improved technologies allow people who have lost limbs to receive rehabilitation as soon as possible, expanding the range of application of the technology almost unlimited within the framework of the target group.
The main advantage of using our technology in the production of new generation prostheses is the flexibility of the platform, which provides unification of the product and extended functionality.
After all, in addition to mechanical actions, our technology can combine all patients with such products into a new network of users, in which the Internet of Things is widely represented and an ever-growing information base, which makes our technologies incredibly attractive to specialized biotechnology companies.
When any client of our company uses this investment offer, it means that his profit from sales when our company sells over 300 package offers and Prosthetics technologies every day, thus enabling this client to earn 0.9% every day.
The creation of technologies for the use of interactive implants reduces the dependence of many patients on donor organs. Using innovative system-on-a-chip ideas, we create not just chips that can run the human nervous system, but also provide technologies that can provide smart monitoring of human organ biorhythms, collecting extensive information and constantly providing data to improve the consumer properties of the product and its further development.
Our improved technologies allow people in need of organ transplants to receive assistance as quickly as possible, expanding the possibilities of rehabilitation of patients and providing them with new opportunities for full life.
The main advantage of using our technology in the production of interactive implants is availability and maximum immune compatibility.
Because when donor organs are used, there is always a high probability of graft rejection, which risks further high costs for drug prevention of these risks. The application of our technology completely eliminates these risks, which makes our interactive implant technologies incredibly attractive to specialized biotechnology companies.
When any client of our company uses this investment offer, it means that his profit from sales when our company sells over 285 package offers and Smart Implants technologies every day, thus enabling this client to earn 1.1% every day.
Creation of technologies for diagnostic equipment is another direction of active development of our company. At creating this technology, we are guided by the extreme demand and importance of using effective diagnostic equipment.
Timely detection at early stages of diseases significantly increases the chances of complete cure, as well as reduces the patient’s treatment costs. In essence, the treatment process can be reduced to certain preventive manipulations, the simplicity of which guarantees their success and effectiveness.
We understand all these advantages and emphasize these developments as preventive treatment technologies.
In addition, our diagnostic equipment technologies also have the ability to create databases, systematize the specifics of a disease’s diagnosis, and use blockchain technology to allow third-party consumers to use some information in the diagnosis of certain diseases.
Our technology can combine and systematize diagnostic information using blockchain technology, transforming into an array of data, making our technology incredibly attractive to specialist biotechnology companies.
When any client of our company uses this investment offer, it means that his profit from sales when our company sells over 250 package offers and Diagnostic equipment technologies every day, thus enabling this client to earn 1.3% every day.
The development of a business direction in which we pay attention to the creation of fundamentally new SoC is almost the most important and productive vector of development of the company as a whole. Using innovative SoC ideas, we create not just chips that can operate under the control of electromagnetic waves emitted by both the human brain and various human body tissues, but also provide completely revolutionary technologies that are able to change and improve the consumer properties of such systems by collecting, processing and applying information resulting from the use of these systems. At the same time, we emphasize the fact that with the growing number of consumers of such products, will accelerate and improve the parameters of the system as a whole, without increasing the cost of use.
The development of chips for the above-mentioned systems is a scientific breakthrough capable of bringing the potential of world biotechnology to a qualitatively new level and providing the needy with incredible yet affordable opportunities to improve human health.
The main advantage of this technology is complete independence and multifunctional functionality, which can be used to create SoC technology with almost unlimited capabilities.
When any client of our company uses this investment offer, it means that his profit from sales when our company sells over 330 package offers and Microchip development technologies every day, thus enabling this client to earn 1.6% every day.
Digital biosystems are an experimental direction of development and strengthening of business of our company. But despite some novelty and experimentality, this direction provides a very high profit for both the company and its investors.
This is explained by the fact that the above-mentioned technology is extremely expensive and therefore used in the most responsible areas of biotechnology. In addition, there is practically no competition in this sector, which has a very positive impact on sales.
In particular, digital biosystems are used in deep space research, as well as in defense and arms-related technologies.
The essence of the technology is that a SoC technology under certain conditions can form a cluster similar to living tissues. These clusters are capable of self-learning and logical chain formation. In addition, they are able to solve problems much faster than traditional computing systems, and they are also able to create digital social connections, which become the image of social media without human involvement.
This technology will change the world in the very near future, creating new opportunities for both humans and biomechanical systems and devices capable of working and making decisions on itsown.
When any client of our company uses this investment offer, it means that his profit from sales when our company sells over 50 package offers and Digital biosystems technologies every day, thus enabling this client to earn 2% every day.
The creation of artificial intelligence is one of the most important tasks of modern times.
Our company provides the world market of biotechnology with unique developments in this vector of business, which have no analogues in the world.
We create artificial intelligence by relying on system-on-chip (SoC) technology, repeatedly revealing the potential of existing technologies.
As a result, we get a product capable of improving the properties of already created Internet of Things, Augmented Reality systems, as well as providing a degree of freedom in the design and creation of blockchain technologies of control and availability of databases and results of applying.
Our research in artificial intelligence has reached an incredible level and at the same time the cost of our development is significantly lower than that of our competitors.
These advantages make our product one of the most popular biotechnologies in the world market and provide new opportunities in the field of neurosurgery and restoration of primary neural connections lost to patients as a result of pathologies of various etymologies.
Uniqueness and the highest efficiency make our artificial intelligence developments the most attractive for the world’s leading biotechnology companies.
When any client of our company uses this investment offer, it means that his profit from sales when our company sells over 85 package offers and Artificial intelligence technologies every day, thus enabling this client to earn 5% every day.
Gerontology now shows steady development and the prospect of growth of achievements in the very long term. Therefore, any effective development of this direction will be among the most profitable from a commercial point of view.
Understanding the importance of the situation, our company has started its own gerontological developments based on the application of SoC technology.
Essence of developments following:
A system of chips divided into functional groups is injected into the human body.
The task of one group, for example, is to monitor chemical processes in the body, the second group collects and classifies information, the third group initiates analysis of data on the basis of which the entire life tone of the human body as a whole will be corrected in almost real time.
This technology, when applied in a comprehensive manner, can significantly increase human life expectancy, reducing the likelihood of most diseases.
In the future, this technology will be accessible to most people and its effectiveness will be further increased.
The sector of technology application is practically unlimited, and constant development gradually reduces the cost of system components.
When any client of our company uses this investment offer, it means that his profit from sales when our company sells over 45 package offers and Gerontology development technologies every day, thus enabling this client to earn 6% every day.
Research in immunology is the most promising and most profitable for all interested persons. If one is able to use the full capabilities of the human immune system, most existing technologies that improve the quality of life and prolong biological life will no longer be necessary.
The fact is that the human body is able to cure itself. To do this, it is simply necessary to stimulate the immune system in a certain way.
Our company is developing technologies that can properly stimulate certain areas of the human immune system, making it resistant to many dangerous diseases.
In the long run, we hope to create immune stimulation technology based on SoC technology that will be able to fully help the human body recover. Which could theoretically lead to a virtually unlimited life span of the human body.
The value and demand of such technology is obvious and at this stage of the company’s business development immune research is the most profitable and economically attractive technology.
Stability of demand and prospects of development make this technology the leader of sales of the company by total cash turnover.
When any client of our company uses this investment offer, it means that his profit from sales when our company sells over 135 package offers and Immune research technologies every day, thus enabling this client to earn 6% every day.
We believe all of this should be free
Our company believes that the whole process of interaction with our clients should be free of charge. Therefore, we do not use hidden or additional fees at the investing process.
Take hold of your benefit!
Stably profit of up to 2% per day for those investing in the future with Nubiotic’s SoC technologies.